Arrowstreet Capital’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76M Buy
1,134,344
+33,529
+3% +$2.45M 0.03% 425
2026
Q1
$84M Sell
1,100,815
-324,991
-23% -$23.4M 0.05% 353
2025
Q4
$91M Buy
1,425,806
+718,502
+102% +$44.3M 0.05% 313
2025
Q3
$44.6M Buy
707,304
+602,677
+576% +$42.1M 0.03% 493
2025
Q2
$7.81M Buy
+104,627
New +$8.22M 0.01% 990
2024
Q2
Sell
-23,260
Closed -$2.33M 1584
2024
Q1
$2.33M Buy
+23,260
New +$2.05M ﹤0.01% 1096
2023
Q1
Sell
-239,177
Closed -$19.5M 1394
2022
Q4
$19.5M Buy
239,177
+31,856
+15% +$2.57M 0.03% 403
2022
Q3
$14.7M Buy
207,321
+89,996
+77% +$8.09M 0.02% 433
2022
Q2
$10.5M Sell
117,325
-54,693
-32% -$5.66M 0.01% 487
2022
Q1
$19.3M Buy
172,018
+159,886
+1,318% +$18.7M 0.02% 405
2021
Q4
$1.47M Buy
+12,132
New +$1.35M ﹤0.01% 1080
2021
Q1
Sell
-2,200
Closed -$221K 2310
2020
Q4
$221K Buy
+2,200
New +$204K ﹤0.01% 2175
2019
Q1
Sell
-116,100
Closed -$8.49M 1769
2018
Q4
$8.49M Buy
+116,100
New +$9.26M 0.02% 468
2018
Q1
Sell
-354,146
Closed -$32.8M 1173
2017
Q4
$32.8M Buy
354,146
+201,200
+132% +$18.3M 0.08% 231
2017
Q3
$13.8M Buy
+152,946
New +$13M 0.04% 325
2017
Q2
Sell
-578,364
Closed -$46.7M 1135
2017
Q1
$46.7M Buy
+578,364
New +$45.5M 0.17% 147
2016
Q4
Sell
-466,535
Closed -$31.6M 1878
2016
Q3
$31.6M Buy
466,535
+255,104
+121% +$17.1M 0.1% 194
2016
Q2
$14.4M Buy
+211,431
New +$15.5M 0.05% 353

Other funds holding EMN

Arrowstreet Capital's EMN Position: Q2 2026 in Review

Arrowstreet Capital increased its Eastman Chemical (EMN) stake by 3% in Q2 2026, buying an estimated $2.45M and bringing the position to 1,134,344 shares worth $76M. The position accounts for 0.03% of the portfolio, ranked #425.

Arrowstreet Capital first reported a position in EMN in Q2 2016 and has held it in 18 quarters since. The position peaked at $91M in Q4 2025. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Arrowstreet Capital held 1,134,344 shares of Eastman Chemical worth $76M as of Q2 2026.
  • Arrowstreet Capital bought 33,529 Eastman Chemical shares in Q2 2026, an estimated $2.45M.
  • Eastman Chemical made up 0.03% of Arrowstreet Capital's portfolio in Q2 2026, its #425 holding.
  • Arrowstreet Capital first reported a position in Eastman Chemical in Q2 2016 and has held it in 18 quarters since.
  • Arrowstreet Capital's Eastman Chemical position peaked at $91M in Q4 2025.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.